Alexander Gutmans

Alexander Gutmans

Partner
Dr. iur., LL.M., Avvocato e Notaio

Sede

Basilea

Contatto

Telefono diretto: +41 58 658 14 51
alexander.gutmans@walderwyss.com

Curriculum Vitae

PDF download

Alexander Gutmans is a partner at Walder Wyss since 2014. He advises national and international clients in the fields of commercial and corporate law, mergers & acquisitions, private equity, venture capital and financings as well as in the field of health care and life sciences in contractual and regulatory matters. As a notary of the canton Basel-Stadt he accompanies his clients in commercial register and real estate register transactions as well as German notarisations. Alexander Gutmans is also active as board member.

Born in 1967, Alexander Gutmans studied at the university of Basel (lic. iur. 1990; Dr. iur. 1995) and Lausanne an received a master’s degree from Yale Law School (LL.M. 1996). In 1993 Alexander Gutmans was admitted as attorney at law and in 2002 as notary. He started his professional career as legal counsel at Sandoz AG and after an assignment as foreign associate with an American law firm in New York he worked during 15 years as a lawyer for a leading Swiss law firm with offices in Basel, Bern and Zurich, during the last 11 years as a partner.

Alexander Gutmans‘ professional work languages are German and English. He also speaks French.

Alentis Therapeutics Raises USD 181.4m in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors

IFLR 1000 Rankings - Walder Wyss as a top-performing law firm ranked

SixPeaks Bio AG debuts with USD 110 million in Funding

Walder Wyss berät P&I Personal & Informatik AG beim Verkauf der Mirus Software AG an Alpha VCX

Axalta Coating Systems Group acquires André Koch AG

Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma

Nouscom Raises €67.5m ($72m) in Oversubscribed Series C Financing Round

Syz Capital und Saturnus Capital investieren in Capture Media

Zusammenschluss von SETEX und Datatex mit Elvaston

CONVOTIS startet mit der Übernahme der JMC Gruppe als Plattformunternehmen in den Schweizer IT Markt und stärkt seine Positionierung im Segment der Managed Services und digitalen Plattformlösungen.

LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

IFLR 1000 Rankings - Walder Wyss as a top-performing law firm ranked

Pierre Fabre Laboratories acquires Vertical Bio AG

Das Familienunternehmen Henke-Sass, Wolf GmbH übernimmt die Zünd Präzisionsoptik AG

DSM and Firmenich have completed their EUR 35 bn merger, becoming the leading creation and innovation partner in nutrition, beauty and well-being

Alentis Therapeutics Closes USD 105m Series C Funding

BC Platforms Announces USD 20 Million Growth Financing led by Jolt Capital

groupe.id joins Elvaston

Versant Ventures launches Vector BioPharma with USD 30m Series A

Elvaston sells Magnolia International AG to GENUI

Beschaffungsmöglichkeiten für Medizinprodukte im Lichte einer drohenden Versorgungslücke in der Schweiz

| di Alexander Gutmans, Simon Olstein, Dennis Zingg e Frederik Weber | in: MedizinProdukteRecht (MPR) 5/2022 | pag. 165-176

Einfuhr und Ausfuhr von Medizinprodukten in der Schwebe

| di Alexander Gutmans, Peter Bürkli e Kassandra Waldvogel | in: MedizinProdukteRecht (MPR) 4/2021

§ 35 Einführung in die Grundlagen und die Systematik des schweizerischen Medizinprodukterechts

| di Michael Isler e Alexander Gutmans [Co-autore] | in: Ehrhard Anhalt / Peter Dieners (Editore) | "Medizinprodukterecht – Praxishandbuch" | 2. Auflage | München | pag. 1201 - 1228

Riconoscimenti